Member Profile

Prof. Rolf C R Ljung
MD, PhD, Professor of Pediatrics

Rolf C. R. Ljung received his medical degree from Lund University, Sweden. His research work has been in the field of coagulation in particular genetic, molecular biological and clinical studies in haemophilia. He is currently Professor of Paediatrics at Lund University and Senior Consultant in Paediatric Haematology at the Department of Paediatrics and at Malmö Haemostasis and Thrombosis Centre, Skåne University Hospital Malmö/Lund.

Dr. Ljung is Scientific Chairman of the "European Paediatric Network for Haemophilia Management" (PedNet) and the International Network on Pediatric Hemophilia (INPH) and co-chairman of the International Prophylaxis Study Group (IPSG). He is a member of the editorial board of Haemophilia, member of the Editorial Committee of Acta Paediatrica and Editor of The International Monitor on Hemophilia and has published numerous papers in professional journals and abstracts in the proceedings of international or national scientific congresses.

Key Publications
  1. Halldén C, Knobe KE, Sjörin E, Nilsson D, Ljung R. Investigation of disease-associated factors in haemophilia A patients without detectable mutations. Haemophilia 2012. Epub ahead of print.
  2. Ljung R, Knobe K. How to manage invasive procedures in children with haemophilia. Brit J. Haematol 2012. Epub ahead of print.
  3.  Halldén C, Nilsson D, Säll T, Lind-Halldén C, Lidén AC, Ljung R. Swedish hemophilia A mutations. J Thromb Haemost. 2012: 10(12):2503-2511.
  4. Gouw SC, van der Bom JG, Ljung R, Escuriola C, Cid AR, Claeyssens-Donadel S, van Geet C, Kenet G, Mäkipernaa A, Claudio Molinari A, Muntean W, Kobelt R, Rivard G, Santagostino E, Thomas A, van den Berg M, for the PedNet and Rodin Study Group. Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med. 2013: 368(3):231-239.
  5.  Gouw S, van den Berg M, Fischer K, Auerswald G, Carcao M, Chalmers E, Chambost H, Kurnik K, Liesner R, Petrini P, Platokouki H, Altisen C, Oldenburg J, Nolan B, Garrido R P, Ljung R, van den Bom J. Intensity of factor VIII treatment and inhibitor development in children with severe haemophilia A: the RODIN study. Blood. 2013: 121(20):4046-55.

Current Positions/Chairs:

  • Professor of Paediatrics
    Lund University, Faculty of Medicine, Department of Clinical Sciences
  • Senior Consultant
    Paediatrics at Skåne University Hospital
  • Scientific Chairman
    European Paediatric Network for Haemophilia Management (PedNet)
  • Scientific Chairman
    International Network for Pediatric Hemophilia (INPH)
  • Co-chairman
    Steering committee for the International Hemophilia Prophylaxis Study Group (IPSG)
  • Member
    Editorial Board of <i>HAEMOPHILIA</i> - The Official Journal of the World Federation of Hemophilia, Wiley-Blackwell
  • Member
    Editorial Committee of Acta Paediatrica
  • Editor
    The International Monitor – Hemophilia, Havas Life Medicom
  • Co-editor
    The International Monitor on von Willebrand Disease, Havas Life Medicom
  • Member
    NovoNordisk European Advisory Board, Zurich
  • Co-chairman
    Bayer International Advisory Board

Key Institutions

  • Lund University
    Paediatric Haematology Research Unit, Paediatrics, Department of Clinical Sciences Lund and the Faculty of Medicine
    Lund and Malmö, Sweden
  • Skåne University Hospital
    Department of Paediatrics
    Lund and Malmö, Sweden

Research Interests

  • Coagulation disorders in children, children in particular genetic and clinical studies on hemophilia

Publications

July 23, 2011

An MRI scale for Assessment of Hemophilic Arthropathy from the International Prophylaxis Study Group

The XXIII International Society on Thrombosis & Haemostasis Congress (July 23-28, 2011 – Kyoto, Japan).
Authors
Lundin B, Manco-Johnson ML, Ignas D, Moineddin R , Babyn P, Blanchette VS, Dunn A , Gibikote SV, Keshava SN, Ljung R, Manco-Johnson MJ ,Miller SF, Rivard GE, Doria AS on behalf of the International Prophylaxis Study Group.
Citation
Award: Red ribbon award for the top ranked 20% of poster presentations.
July 1, 2011

An MRI scale for assessment of hemophilic arthropathy from the International Prophylaxis Study Group

Haemophilia 2012 Nov; 18 (6):962-70
Authors
Lundin B, Manco-Johnson ML, Ignas DM, Moineddin R, Blanchette VS, Dunn AL, Gibikote SV, Keshava SN, Ljung R, Manco-Johnson MJ,Miller SF, Rivard GE, Doria AS on behalf of the International Prophylaxis Study Group.
Citation
Accepted to the XXIII International Society on Thrombosis and Haemostasis Congress (July 23-28, 2011 – Koyoto, Japan).
May 16, 2008

Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG).

Authors
Feldman BM, Funk S, Lundin B, Doria AS, Ljung R, and Blanchette V.
Citation
Haemophilia 2008, 14 (Suppl. 3), 162-169.
March 4, 2006

Are randomized clinical trials the only truth? Not always

Authors
Aledort L, Ljung R, and Blanchette V on behalf of the International Prophylaxis Study Group (IPSG)
Citation
Journal of Thrombosis and Haemostasis 2006 Mar; 4 (3): 503 - 504.
March 15, 2005

Compatible scales for progressive and additive magnetic resonance imaging assessments of haemophilic arthropathy.

Authors
Lundin B, Nuss R, Kilcoyne R, Doria A, Pettersson H, and Ljung R.
Citation
Haemophilia 2004 Oct; 10 (S3): 79 # 16 S 02.
October 17, 2004

Compatible scales for progressive and additive magnetic resonance imaging assessments of haemophilic arthropathy

The XXVI World Federation of Hemophillia Congress (October 17-21, 2004 - Bangkok, Thailand).
Authors
Lundin B, Nuss R, Kilcoyne R, Doria A, Pettersson H, and Ljung R
Citation